Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
Clinical trial NCT00766337 · TERMINATED
Trial details
- NCT number
- NCT00766337
- Sponsor
- Santen Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-11-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.